本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

37.90
+2.336.55%
盤後35.00-2.9000-7.65%17:11 EDT
成交量:285.94萬
成交額:1.04億
市值:12.20億
市盈率:-11.67
高:38.25
開:33.89
低:33.23
收:35.57
52周最高:38.25
52周最低:13.37
股本:3,218.83萬
流通股本:1,345.91萬
量比:1.52
換手率:21.25%
股息:- -
股息率:- -
每股收益(TTM):-3.2490
每股收益(LYR):-2.5506
淨資產收益率:-34.71%
總資產收益率:-23.37%
市淨率:4.03
市盈率(LYR):-14.86

資料載入中...

2024/02/08

SEC問詢函

Form CORRESP - Correspondence
2024/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/25

重要事件披露

Form 8-K - Current report
2023/10/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]